Company intelligence
Orion Pharma
Building well-being means the world to us.
About Orion Pharma
Orion Pharma is a globally operating Nordic pharmaceutical company – a builder of well-being for over a hundred years. We develop, manufacture and market human and veterinary pharmaceuticals as well as active pharmaceutical ingredients, combining our trusted expertise with continuous innovation. We have an extensive portfolio of proprietary and generic medicines and consumer health products. The core therapy areas of our pharmaceutical R&D are oncology and pain. Proprietary products developed by us are used to treat cancer, respiratory diseases and neurological diseases, among others. In 2025 our net sales amounted to EUR 1,890 million and we employ about 4,000 professionals worldwide, dedicated to building well-being. Product related questions and feedback: https://www.orionpharma.com/feedback Beware of any recruitment scam using Orion Pharma’s name Be cautious of recruitment scams where individuals pose as Orion Pharma employees or authorized recruiters. Orion Pharma will never request payment, personal financial information, or any favours at any stage of our hiring process.
Verified activity
Signals from Orion Pharma
10 published signals
Presence & Recognition
Orion Pharma team is on site in Barcelona at the ERS2026 event to connect and exchange perspectives across the respiratory community.
Reported by Orion Pharma
Research & Knowledge
Orion Pharma researcher Anu Moilanen and Olli Törmäkangas Chemistry Lead, Medicinal Chemistry, discovered a molecule that went on to become a treatment for people living with prostate cancer.
Reported by Orion Pharma
Presence & Recognition
Orion Pharma is organizing the Industry Skills Lab session on Sunday 6 September at 15:45–16:30 in room 3M for the ERS 2026 congress.
Reported by Orion Pharma
Research & Knowledge
Orion Pharma scientists discovered a novel medicine for patients with prostate cancer and are working in the company's R&D department.
Reported by Outi Vaarala
People
Orion Pharma wrapped the Phase1 Trainee Programme 2026 for its summer trainees across research and engineering to business operations and beyond.
Reported by Orion Pharma
Partnerships
Orion Pharma collaborates with the CMI — Martti Ahtisaari Peace Foundation to support the #PrescriptionsforPeace initiative.
Reported by Orion Pharma
People
Orion Pharma is hiring a Medical Scientific Liaison for Anna-Kaisa Laine.
Reported by Elina Tuisku
Research & Knowledge
Orion Pharma featured Anu Moilanen and Olli Törmäkangas on a molecule that became a treatment for people living with prostate cancer.
Reported by Orion Pharma
People
Orion Pharma is hiring a new Läkeesittelijä for the Orion Geneeristen Rekrytointi-Organisaatiot (ORG) to work with the customer and partner side of the supply chain.
Reported by Elina Tuisku
Presence & Recognition
Orion Pharma is attending the European Respiratory Society International Congress 2026 with representatives including Henri Salokangas, Paula Rytilä, Franziska Ewald, Charles de Wet, Rafael Carballo Gris, and Francesca Silvestri.
Reported by Orion Pharma